Search

Your search keyword '"Boschetti, C."' showing total 23 results
Start Over Author "Boschetti, C." Language undetermined
23 results on '"Boschetti, C."'

1. Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Author

Rondelli T, Peffault de Latour R, Sica M, Peruzzi B, Ricci P, Barcellini W, Iori AP, Boschetti C, Valle V, Frémeaux Bacchi V, De Angioletti M, Socié G, Luzzatto L, Notaro R., RISITANO, ANTONIO MARIA, Rondelli, T, Risitano, ANTONIO MARIA, Peffault de Latour, R, Sica, M, Peruzzi, B, Ricci, P, Barcellini, W, Iori, Ap, Boschetti, C, Valle, V, Frémeaux Bacchi, V, De Angioletti, M, Socié, G, Luzzatto, L, and Notaro, R.

Published
2014

3. Chronic hepatitis c virus infection and primary cutaneous B-cell lymphoma

Author

Prati, D, Zanella, A, De Mattei, C, Farma, E, Boschetti, C, Sirchia, G, Venegoni, L, Berti, E., Prati, D, Zanella, A, De Mattei, C, Farma, E, Boschetti, C, Sirchia, G, Venegoni, L, and Berti, E

Subjects
Hepatitis Antibodie, Lymphoma, B-Cell, Skin Neoplasms, MED/15 - MALATTIE DEL SANGUE, MED/35 - MALATTIE CUTANEE E VENEREE, Humans, Skin Neoplasm, Hepatitis Antibodies, Hepatitis C, Chronic, Human
Published
1999

12. Current standard of care in patients affected by coronary heart disease in Italy: The MC'95 study

Author

Magnani, B., Dal Palù, C., Zanchetti, A., Paciaroni, E., Rafaeli, S., Rizzon, P., Del Laura, D., Bracchetti, D., Rubboli, A., Leonardi, G., Visioli, O., Assanelli, D., Cherchi, A., Lai, C., Fusco, C., Sanna, A., Marras, L., Crabu, E., Lazzaroli, A., Chieff, C., Di Stasio, M., Giuffrida, G., Passaniti, A., Calvi, V., Pretolani, E., Pretolani, M., Barsotti, A., Gallina, S., Finis, A., Gaeta, M., Padula, M., Plastina, F., Battista, F., Gensini, G. F., Del Pace, S., Comeglio, M., Caponnetto, S., Maragliano, P., Delfino, L., Santucci, A., Gentile, M., Giulani, E., Bellini, C., Bossi, M., Alessandro, B., Arrigo, E., Luzza, F., Frisina, N., Piccolo, E., Ragazzo, M., Fiorentini, C., Beltrami, A., Panna, S., Lanzafame, A. S., Libretti, A., Colombo, F., Polese, A., Benevento, F., Lavezzaro, G., Spinnler, M. T., Cobelli, F., Parziale, P., Chiariello, M., Perrone Filardi, P., Betocchi, S., Divitiis, O., Di Somma, S., Cudemo, G., Carotenuto, A., Sensale, P., Trevi, G. P., Magnani, A., Novo, S., Raineri, A., Marcello Traina, Leone, S., Borghetti, A., Cavatorta, A., Arisi, S., Adornini, G., Corea, L., Mariotti, M., Mariani, M., Biadi, O., Campa, P. P., Mastroianni, M. A., Plaustro, G., Prati, P., Boschetti, C., Pulcini, M., Santini, M., Magris, B., Strano, A., Sanguigni, V., Bru-Sca, A., Caruzzo, C., Milone, F., and Garbo, R.

19. Long-term results in non randomized patients with acute myelogenous leukemia: A single institution experience

Author

Gl, Deliliers, Annaloro C, Oriani A, Della Volpe A, Boschetti C, AGOSTINO CORTELEZZI, and At, Maiolo

Subjects
Adult, Male, Adolescent, Leukemia, Myeloid, Acute Disease, Antineoplastic Combined Chemotherapy Protocols, Remission Induction, Cytarabine, Humans, Female, Middle Aged, Idarubicin, Bone Marrow Transplantation
Abstract

Sixty-three non randomized adults with acute myelogenous leukemia were treated with an idarubicin-based protocol. The patients achieving complete remission received autologous bone marrow transplantation or (if50 years or refusing autologous bone marrow transplantation) high-dose Ara-C, as late intensification. Fifty-two patients (82.5%) achieved complete remission, 45 after one induction course and 16 of them underwent autologous bone marrow transplantation a median of 11 months later. As of December 1997 (median follow-up 112 months, range 50-135 months), 16 patients were still in complete remission (10 after autologous bone marrow transplantation, 6 after high-dose Ara-C) and 29 had relapsed (median time to relapse 14 months, range 2-75 months). Four patients died in complete remission. The median disease-free survival was 25 months; the 50-months and 10-year disease-free survival were 41% and 35% respectively. No significant differences were observed between the autologous bone marrow transplantation and high-dose Ara-C treated patients whose complete remission had lasted more than 11 months. The median disease-free survival in the autografted patients had not been reached after 120 months (the 50-month and 10-year disease-free survival chances were both 67%). Age was the only predictive variable for leukemic relapse. These long-term results confirm the antileukemic efficacy of an idarubicin-containing protocol, which led to high complete remission rates and favorably influenced disease-free survival. Furthermore, the efficacy of late intensification treatment with either autologous bone marrow transplantation or high-dose Ara-C is underscored. The disease-free survival chances after autologous bone marrow transplantation are comparable with those published for allogeneic bone marrow transplantation; however, disease-free survival of the patients receiving a high-dose Ara-C intensification regimen is not significantly worse than that seen after autologous bone marrow transplantation.

21. Clinical management of squamous cell carcinoma of the tongue: patients not eligible for free flaps, a systematic review of the literature

Author

Raffaele Rauso, Giuseppe Colella, Brigida Iorio, Davide De Cicco, Ciro Emiliano Boschetti, Gianpaolo Tartaro, Chiara Spuntarelli, Renato Franco, Colella, G., Rauso, R., De Cicco, D., Boschetti, C. E., Iorio, B., Spuntarelli, C., Franco, R., and Tartaro, G.

Subjects
squamous cell carcinoma, 0301 basic medicine, medicine.medical_specialty, reconstruction, medicine.medical_treatment, Surgical Flaps, scc, head and neck, surgery, 03 medical and health sciences, 0302 clinical medicine, Tongue, medicine, cancer, Humans, Pharmacology (medical), Basal cell, Head and neck, Radiation treatment planning, maxillofacial, Squamous Cell Carcinoma of Head and Neck, business.industry, Cancer, Plastic Surgery Procedures, Ablation, medicine.disease, Tongue Neoplasms, Surgery, stomatognathic diseases, 030104 developmental biology, medicine.anatomical_structure, Oncology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Head and neck surgery, Free flap reconstruction, flap, business
Abstract

Introduction: The management of squamous cell carcinoma (SCC) of the tongue represents the most demanding treatment planning in head and neck surgery. Ablation followed by free flap reconstruction is considered the gold standard, but not all patients are suitable for this strategy. The aim of this review is to provide a comprehensive view of surgical reconstruction possibilities in patients not eligible for free flaps. Methods: Following PRISMA recommendations, a systematic literature review was conducted searching for original papers that investigated outcomes of patients treated by surgical ablation for tongue SCC followed by reconstruction with local or pedicled flaps. Selected papers were read and data extracted for qualitative analysis. Results: Twenty articles met the inclusion/exclusion criteria. The study design was case series in sixteen papers, cohort study in the remaining four. Four different local flaps (BMM, FAMM, NLIF, SMIF) and four regional flaps have been discussed in included studies (IHF, SFIF, SCM, PMMC). Conclusion: The improved anatomical knowledge makes local flaps a reliable alternative to free tissue transfer in cases requiring small-/medium-sized defects. Regional flaps still represent cornerstones in reconstruction of the tongue. Ease of execution, costs-to-benefit ratio, low-rate complications, minimal donor site morbidity represent the best advantages choosing local/regional flaps.

Published
2020
Full Text
View/download PDF

22. Myoepithelioma of the parotid gland: A case report with review of the literature

Author

Ida Barca, Maria Giulia Cristofaro, Raffaella Cordaro, Walter Colangeli, Carmelo Lo Faro, Daniela Novembre, Ciro Emiliano Boschetti, Amerigo Giudice, Barca, I., Novembre, D., Cordaro, R., Lo Faro, C., Colangeli, W., Boschetti, C. E., Giudice, A., and Cristofaro, M. G.

Subjects
Pathology, medicine.medical_specialty, Myoepithelioma, business.industry, Left parotid gland, lcsh:Surgery, 030206 dentistry, lcsh:RD1-811, World health, Malignant transformation, Parotid gland, 03 medical and health sciences, Rare tumor, 0302 clinical medicine, medicine.anatomical_structure, Otorhinolaryngology, stomatognathic system, 030220 oncology & carcinogenesis, Medicine, Surgery, Oral Surgery, business
Abstract

Myoepithelioma is a rare tumor of the salivary glands belonging to a distinct category of neoplasms according to World Health Organization. It represents about 1% of all tumors that develop in the salivary glands. Generally the majority of myoepitheliomas are benign but malignant transformation can take place in untreated or recurrent cases. We present a case of a rare myoepithelioma of the left parotid gland, with review of literature. Keywords: Parotid gland, Salivary glands myoepithelioma, Benign salivary glands tumors, Myoepithelioma, Spindle cells myoepithelioma

Published
2020

23. Immunoregulatory cytokine polymorphisms in Italian patients affected by paroxysmal nocturnal haemoglobinuria and aplastic anaemia

Author

Elisa Fermo, Carla Boschetti, Fiorella Alfinito, Wilma Barcellini, Paola Pedotti, Paola Bianchi, Alberto Zanella, Agostino Cortelezzi, Fermo, E, Bianchi, P, Barcellini, W, Pedotti, P, Boschetti, C, Alfinito, Fiorella, Cortelezzi, A, and Zanella, A.

Subjects
Polymorphism, Genetic, Genotype, medicine.medical_treatment, Immunology, Hemoglobinuria, Paroxysmal, Bone marrow failure, Anemia, Aplastic, Interleukin, Biology, medicine.disease, Pathogenesis, Cytokine, Gene Frequency, Interferon, Genetics, medicine, Cytokines, Humans, Tumor necrosis factor alpha, Hemoglobinuria, medicine.drug, Transforming growth factor
Abstract

We investigated regulatory variants of five cytokine genes [tumour necrosis factor (TNF)-alpha, interferon (IFN)-gamma, transforming growth factor (TGF)-beta, interleukin (IL)-6 and IL-10] in 40 Italian patients affected by paroxysmal nocturnal haemoglobinuria (PNH) and aplastic anaemia (AA). Genotypes associated with high production of TGF-beta and IFN-gamma were more frequent in patients than in controls. Genetic regulation of the immunological pathways involved in the pathogenesis of bone marrow failure is suggested.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results